Anjali Shinde Selected Research

Anjali Shinde Research Topics

5	Neoplasms (Cancer) 12/2023 - 01/2021
5	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 02/2024 - 02/2024
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 04/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 01/2021
2	Inflammation (Inflammations) 12/2023 - 01/2021
2	Triple Negative Breast Neoplasms 12/2022 - 01/2021
2	Bites and Stings (Sting) 12/2022 - 01/2021
1	Fragile X Tremor Ataxia Syndrome 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2021
1	Erythema Multiforme 02/2019
1	Urinary Tract Infections (Urinary Tract Infection) 02/2019
1	Blister (Bulla) 02/2019
1	Aneurysmal Bone Cysts 01/2006
1	Carcinoma (Carcinomatosis) 09/2005
1	Hepatocellular Carcinoma (Hepatoma) 09/2005

3	CytokinesIBA 12/2023 - 04/2021
2	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2021
2	Infliximab (Remicade)FDA Link 12/2023 - 12/2023
2	Monoclonal AntibodiesIBA 12/2023 - 12/2023
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 02/2024
1	ChemokinesIBA 12/2023
1	VimentinIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	InterferonsIBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 04/2021
1	Phenobarbital (Luminal)FDA Link 04/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021
1	ProteomeIBA 04/2021
1	SynucleinsIBA 04/2021
1	cyclic diadenosine phosphateIBA 01/2021
1	5' Untranslated Regions (5' UTR)IBA 01/2021
1	Caspase 9IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Cephalexin (Cefalexin)FDA LinkGeneric 02/2019
1	Coloring Agents (Dyes)IBA 01/2006
1	AntibodiesIBA 01/2006
1	AntigensIBA 09/2005